Recognizing the urgency of healthcare affordability, I propose an end to the perpetual patent renewal of insulin types, breaking the chains of government-protected monopolies. By rekindling the spirit of the original $1 insulin patent, we can relieve the burden on patients and families while fostering competition and innovation.

Together, let's ensure that this life-sustaining medication remains accessible to all who need it, reflecting our commitment to health, equity, and compassion.